| Chautauqua Hospice And Palliative Care 20 West Fairmount Avenue, Lakewood, NY, 14750 | |
| (716) 338-0033 |
News Archive
The University's School of Social Community & Health Studies has won a three year contract worth one million pounds a year with the East of England Strategic Health Authority to implement training for a major government policy in mental health entitled Improving Access to Psychological Therapies (IAPT).
AstraZeneca today announced that the US Food and Drug Administration has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
Survey results released by the American College of Preventive Medicine (ACPM) found that nearly half (48%) of U.S. adults 40+ with diabetes are not utilizing aspirin therapy to reduce their risk of recurrent heart attack or stroke nor had they reported discussing such therapy with their healthcare provider.
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
› Verified 2 days ago
| Name | Chautauqua Hospice And Palliative Care |
|---|---|
| Location | 20 West Fairmount Avenue, Lakewood, New York |
| Hospice ID | 331554 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| SSA county code | 060 |
News Archive
The University's School of Social Community & Health Studies has won a three year contract worth one million pounds a year with the East of England Strategic Health Authority to implement training for a major government policy in mental health entitled Improving Access to Psychological Therapies (IAPT).
AstraZeneca today announced that the US Food and Drug Administration has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
Survey results released by the American College of Preventive Medicine (ACPM) found that nearly half (48%) of U.S. adults 40+ with diabetes are not utilizing aspirin therapy to reduce their risk of recurrent heart attack or stroke nor had they reported discussing such therapy with their healthcare provider.
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
› Verified 2 days ago
| NPI Number | 1639255250 |
| Organization Name | Chautauqua Hospice And Palliative Care |
| Address | 20 West Fairmount Ave Lakewood, New York, 14750 |
| Phone Number | (716)338-0033 |
News Archive
The University's School of Social Community & Health Studies has won a three year contract worth one million pounds a year with the East of England Strategic Health Authority to implement training for a major government policy in mental health entitled Improving Access to Psychological Therapies (IAPT).
AstraZeneca today announced that the US Food and Drug Administration has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
Survey results released by the American College of Preventive Medicine (ACPM) found that nearly half (48%) of U.S. adults 40+ with diabetes are not utilizing aspirin therapy to reduce their risk of recurrent heart attack or stroke nor had they reported discussing such therapy with their healthcare provider.
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
› Verified 2 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.8 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 95.5 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 94.8 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 67.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 80.4 | 97.3 |
| Patients who got timely treatment for shortness of breath | 95.5 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 84.9 | 93.3 |
News Archive
The University's School of Social Community & Health Studies has won a three year contract worth one million pounds a year with the East of England Strategic Health Authority to implement training for a major government policy in mental health entitled Improving Access to Psychological Therapies (IAPT).
AstraZeneca today announced that the US Food and Drug Administration has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
Survey results released by the American College of Preventive Medicine (ACPM) found that nearly half (48%) of U.S. adults 40+ with diabetes are not utilizing aspirin therapy to reduce their risk of recurrent heart attack or stroke nor had they reported discussing such therapy with their healthcare provider.
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
› Verified 2 days ago
| Home Health Aides | 11.85 |
| Counselors | 3 |
| Homemakers | 1 |
| Licensed Practical or Vocational Nurses | 6 |
| Medical Social Workers | 4.16 |
| Physicians | 1 |
| Registered Nurses | 17.5 |
| Other Personnel | 11 |
| Total Employees | 55.51 |
|---|
News Archive
The University's School of Social Community & Health Studies has won a three year contract worth one million pounds a year with the East of England Strategic Health Authority to implement training for a major government policy in mental health entitled Improving Access to Psychological Therapies (IAPT).
AstraZeneca today announced that the US Food and Drug Administration has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
Survey results released by the American College of Preventive Medicine (ACPM) found that nearly half (48%) of U.S. adults 40+ with diabetes are not utilizing aspirin therapy to reduce their risk of recurrent heart attack or stroke nor had they reported discussing such therapy with their healthcare provider.
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
› Verified 2 days ago
| Others | 48 |
| Total Volunteers | 48 |
|---|
News Archive
The University's School of Social Community & Health Studies has won a three year contract worth one million pounds a year with the East of England Strategic Health Authority to implement training for a major government policy in mental health entitled Improving Access to Psychological Therapies (IAPT).
AstraZeneca today announced that the US Food and Drug Administration has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
Survey results released by the American College of Preventive Medicine (ACPM) found that nearly half (48%) of U.S. adults 40+ with diabetes are not utilizing aspirin therapy to reduce their risk of recurrent heart attack or stroke nor had they reported discussing such therapy with their healthcare provider.
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
› Verified 2 days ago
| Chautauqua Hospice And Palliative Care Location: 20 West Fairmount Avenue, Lakewood, New York, 14750 Phone: (716) 338-0033 |